For citations:
Losev I.V., Donina S.A., Petukhova G.D., Erofeeva M.K., Rudenko L.G., Naykhin A.N. APPLICATION OF METHOD BASED ON IN VITRO ANTIBODY QUANTIFICATION IN PBMC SUPERNATANT SAMPLES FOR IMMUNOGENICITY EVALUATION OF A (H5N1) AND A (H5N2) POTENTIALLY PANDEMIC INFLUENZA VACCINES IN CLINICAL TRIALS. Medical Immunology (Russia). 2016;18(2):129-138. (In Russ.) https://doi.org/10.15789/1563-0625-2016-2-129-138
Email this article 